
Maven backs £6.5m buyout of Healthpoint
Maven Capital Partners has backed the £6.5m management buyout of UK-based healthcare and beauty products supplier Healthpoint.
The deal's capital was raised through Maven's co-investment network and supported by a Barclays financing package consisting of buyout debt and working capital.
Healthpoint's fresh funding will be deployed in support of developing new products and driving organic growth. In a statement, Maven said the company would also consider a buy-and-build strategy with follow-on funding available for bolt-ons.
Company
Headquartered in Blackpool, Healthpoint is a manufacturer of personal care and beauty products.
In addition to its personal care and beauty portfolio, the company also sells over-the-counter medicines under the Healthpoint brand. It expects to expand this product line after Maven's investment.
People
Maven Capital Partners – Ryan Bevington (investment director).
Healthpoint – Amanda Parkinson (managing director).
Advisers
Equity – UNW, Paul Kaiser, Katy Lamb, Stephanie Davidson (corporate finance, tax); Gately, Paul Jefferson, Katie Porter (legal); RPL (commercial due diligence); Vista (insurance due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater